Literature DB >> 26314810

Association of inflammatory bowel disease with asthma risk: A nationwide cohort study.

Yi-Hao Peng1, Wei-Chih Liao, Ching-Hua Su, Hsuan-Ju Chen, Te-Chun Hsia, Chia-Chen Chu, Chin-Jung Liu, Chia-Hung Kao.   

Abstract

OBJECTIVE: We evaluated the risk of asthma development in adult patients with inflammatory bowel disease (IBD) in a nationwide population.
METHODS: A retrospective cohort study was conducted by using data retrieved from the Taiwan National Health Insurance Research Database. Patients, ages 20 year or older, with newly diagnosed IBD between 2000 and 2005 were identified and randomly frequency-matched (based on sex, age, and index year) with four times the number of enrollees without IBD from the general population. Both cohorts were followed up until the end of 2011 to examine the incidence of asthma. Cox proportional hazard regression analysis was used to measure the hazard ratios (HR) of asthma in the IBD cohort compared with that in the non-IBD cohort.
RESULTS: The IBD and non-IBD cohorts comprised 5260 patients with IBD and 21,040 participants, respectively. After adjustment for covariates, the IBD cohort exhibited a 1.50-fold increased risk for asthma (HR 1.50, [95% confidence interval {CI}, 1.32-1.71]). Further analysis according to the two major forms of IBD revealed that the adjusted HR of asthma was 1.46 (95% CI, 1.03-2.07) and 1.50 (95% CI, 1.31-1.72) in patients with ulcerative colitis and Crohn's disease, respectively, compared with the non-IBD cohort.
CONCLUSION: After adjustment for comorbidities, patients with IBD were associated with a higher subsequent risk of asthma.

Entities:  

Mesh:

Year:  2015        PMID: 26314810     DOI: 10.2500/aap.2015.36.3869

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  8 in total

1.  Children at risk: Conditions which can increase the occurrence of allergic disease.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2015 Sep-Oct       Impact factor: 2.587

2.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

3.  Current Knowledge and Future Research Directions on Fecal Bacterial Patterns and Their Association with Asthma.

Authors:  Shantelle Claassen-Weitz; Charles S Wiysonge; Shingai Machingaidze; Lehana Thabane; William G C Horsnell; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  Front Microbiol       Date:  2016-06-29       Impact factor: 5.640

4.  Intratracheal Ovalbumin Administration Induces Colitis Through the IFN-γ Pathway in Mice.

Authors:  Kyoung-Hwa Jung; Dasom Shin; Sejun Kim; Daeun Min; Woogyeong Kim; Jinju Kim; Gihyun Lee; Hyunsu Bae
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

5.  Prevalence of allergic diseases in children with inflammatory bowel disease.

Authors:  Zuzanna Wasielewska; Aleksandra Dolińska; Dominika Wilczyńska; Anna Szaflarska-Popławska; Aneta Krogulska
Journal:  Postepy Dermatol Alergol       Date:  2019-06-18       Impact factor: 1.837

6.  Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study.

Authors:  Claudio Barbiellini Amidei; Fabiana Zingone; Loris Zanier; Cristina Canova
Journal:  Int J Environ Res Public Health       Date:  2020-06-15       Impact factor: 3.390

7.  Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.

Authors:  M Ellen Kuenzig; Kirles Bishay; Richard Leigh; Gilaad G Kaplan; Eric I Benchimol
Journal:  Clin Transl Gastroenterol       Date:  2018-09-24       Impact factor: 4.488

8.  Expression profiling of ileal mucosa in asthma reveals upregulation of innate immunity and genes characteristic of Paneth and goblet cells.

Authors:  Jan K Nowak; Marzena Dworacka; Nazgul Gubaj; Arystan Dossimov; Zhumabek Dossimov; Jarosław Walkowiak
Journal:  Allergy Asthma Clin Immunol       Date:  2021-07-31       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.